Alexander V. Ljubimov
Corporate Officer/Principal bij Regenerative Medicine Institute
Profiel
Alexander V.
Ljubimov was the founder of Arrogene, Inc. which was founded in 2006, where he held the title of Senior Vice President-Research.
Currently, he is the Director-Eye Program at Regenerative Medicine Institute.
Previously, he worked as the Director at Cedars-Sinai Medical Center.
Actieve functies van Alexander V. Ljubimov
| Bedrijven | Functie | Begin |
|---|---|---|
| Regenerative Medicine Institute | Corporate Officer/Principal | - |
Eerdere bekende functies van Alexander V. Ljubimov
| Bedrijven | Functie | Einde |
|---|---|---|
Cedars-Sinai Medical Center
 Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
Arrogene, Inc.
 Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Health Services |
| Regenerative Medicine Institute | |
Arrogene, Inc.
Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Health Technology |
